Top Markets
Coin of the day
Viropro Inc. Viropro Inc.

Viropro Inc.

VPRO
Rang in Aktien #41343
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract... Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeutic proteins through the licensing of its proprietary technologies, targeting illnesses like cancer, diabetes, hepatitis, and multiple sclerosis. Viropro manufactures a range of biologics drugs, including biosimilars, for use across all phases of clinical development, from pre-clinical studies through Phase I, II, and III trials. Its offerings to clients include the provision of mammalian cell proteins, such as monoclonal antibodies, recombinant proteins, and other cell-derived compounds. Notably, the firm owns three proprietary clones: two intended for insulin-related therapies and one for cancer treatment. Viropro delivers extensive contractual research and manufacturing solutions to biotech and biopharmaceutical enterprises, performing tasks such as cloning, sequencing, purification, development, validation, and production of biopharmaceutical components and finished products. The company maintains operational presences in Canada, the United Kingdom, and Malaysia, and has established a partnership with Oncobiologics, Inc. for the creation and commercialization of monoclonal antibody products. Viropro Inc. is headquartered in San Jose, California.
Aktienkurs
$0.00002
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$25.40K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-80.00%
Land
US
Handel Viropro Inc. (VPRO)

Kategorie

Preis VPRO mit Marktkapitalisierung von B
Viropro Inc. Viropro Inc.
VPRO
$0.00002
Marktkapitalisierung von Viropro Inc.(VPRO)
Marktkapitalisierung: $25.40K
Mit Stand August 2026 hat Viropro Inc. eine Marktkapitalisierung von $25.40K. Das macht Viropro Inc. laut unseren Daten zum 41343rd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Viropro Inc. von 1995 bis 2026
VPRO im Vergleich zu den Top 5 der beliebtesten stocks
Preis für VPRO Vermögenswert B Marktkapitalisierung von B Ergebnisse
Viropro Inc. Viropro Inc.
$4,238.20 $25.40K
$5.383T +21,190,991,318.67%
Viropro Inc. Viropro Inc.
$3,482.44 $25.40K
$4.423T +17,412,183,822.76%
Viropro Inc. Viropro Inc.
$3,275.37 $25.40K
$4.160T +16,376,827,954.96%
Viropro Inc. Viropro Inc.
$2,884.05 $25.40K
$3.663T +14,420,251,974.48%
Viropro Inc. Viropro Inc.
$2,276.20 $25.40K
$2.891T +11,380,998,149.88%